Trials / Completed
CompletedNCT00361530
Carotid Intima-media Thickness in Japan Statin Treatment Against Recurrent Stroke(J-STARS Echo)
Effect of 3-hydroxy-3-methylglutaryl-coenzyme A(HMG-CoA) Reductase Inhibitor Upon Carotid Intima-media Complex Thickness in the Post-ischemic Patients With Hyperlipidemia During the Prospective Study of J-STARS.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 854 (actual)
- Sponsor
- Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan · Academic / Other
- Sex
- All
- Age
- 45 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Carotid ultrasound can reveal the intima-media complex thickness(IMT), that has been reported to be a marker of atherosclerosis as well as a risk of cardiovascular events, and to be attenuated by 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins) . This substudy of J-STARS will observe the temporal profile of carotid IMT prospectively in the patients with prescription of pravastatin and the control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Statin |
Timeline
- Start date
- 2004-03-01
- Primary completion
- 2014-07-01
- First posted
- 2006-08-08
- Last updated
- 2016-04-25
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00361530. Inclusion in this directory is not an endorsement.